Lenacapavir: Twice-Yearly Injectable PrEP
Lenacapavir is a long-acting injectable antiretroviral medicine used as Pre-Exposure Prophylaxis (PrEP) to prevent HIV. Unlike daily pills, Lenacapavir is administered as an injection under the skin just once every six months (twice a year).
How Lenacapavir Works
Lenacapavir belongs to a class of medicines called capsid inhibitors. It blocks the protein shell (capsid) that protects HIV's genetic material, stopping the virus at multiple stages of its life cycle before it can establish an infection in the body.
Why Twice-Yearly PrEP Matters for Young People
- Only two clinic visits per year: Removes the pressure of remembering a pill every single day.
- High privacy and discretion: No pill bottles to store at home or carry when traveling, reducing stigma.
- Breakthrough trial results: Clinical studies such as the PURPOSE trials showed near-complete protection against HIV infection when administered on schedule.
Important Things to Know
Before starting Lenacapavir, you must take an HIV test to confirm you are HIV-negative. While Lenacapavir protects against HIV, it does not protect against other sexually transmitted infections (STIs) or unintended pregnancy, so pairing it with condoms remains a smart choice.